MOLN.SW SIX
Molecular Partners AG
1W: +3.4%
1M: -4.9%
3M: +3.1%
YTD: -6.2%
1Y: +14.4%
3Y: -35.2%
5Y: -81.6%
CHF 3.33 ($4.02)
-0.01 (-0.30%)
Weekly Expected Move ±6.3%
CHF 3
CHF 3
CHF 3
CHF 4
CHF 4
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Cash Flow Trends
Operating Cash Flow
-$50M
+16.4% ▲
Capital Expenditures
$714K
+1.2% ▲
5Y CAGR: -15.8%
Free Cash Flow
-$50M
+16.2% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$56M
-1541.4% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$64M | $118M | -$62M | -$54M | -$62M |
| Depreciation & Amort. | $3M | $2M | $2M | $2M | $0 |
| Stock-Based Comp. | $4M | $5M | $5M | $4M | $0 |
| Change in Working Capital | -$35M | -$6M | -$6M | -$4M | $1M |
| Other Non-Cash Items | $848K | -$753K | $1M | -$8M | $11M |
| Operating Cash Flow | -$91M | $119M | -$59M | -$59M | -$50M |
| — Investing Activities — | |||||
| Capital Expenditures | -$1M | -$1M | -$808K | -$705K | -$714K |
| Acquisitions (Net) | $374K | $0 | $0 | $0 | $0 |
| Investment Purchases | -$89M | -$299M | -$278M | -$240M | $0 |
| Investment Sales | $68M | $199M | $319M | $277M | $0 |
| Other Investing | -$304K | $494K | $4M | $4M | $72M |
| Investing Cash Flow | -$22M | -$101M | $45M | $40M | $71M |
| — Financing Activities — | |||||
| Net Debt Issuance | -$1M | -$1M | -$1M | -$1M | -$1M |
| Stock Repurchased | $0 | -$631K | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $267K | $250K | $31K | -$2M | $0 |
| Financing Cash Flow | $51M | -$2M | -$1M | $14M | -$1M |
| Net Change in Cash | -$62M | $16M | -$21M | -$3M | -$56M |
| Cash End of Period | $72M | $88M | $67M | $64M | $93M |
| Free Cash Flow | -$92M | $117M | -$60M | -$60M | -$50M |